Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Crohn's Disease Excellence Forum

Crohn's Disease
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Neil Hyman
Conference Coverage
Neil Hyman, MD, on Surgery as First-Line Therapy for Penetrating Crohn Disease
05/16/2023
Dr Hyman explains how surgery can be a highly efficacious option for first-line therapy of penetrating Crohn disease.
Dr Hyman explains how surgery can be a highly efficacious option for first-line therapy of penetrating Crohn disease.
Dr Hyman explains how surgery...
05/16/2023
Advances in Inflammatory Bowel Disease Network
crohn disease+IBD
Conference Coverage
Is Resection A Better Alternative to Medical Therapy in Early Ileocecal Crohn Disease?
05/07/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Dr Manasi Agrawal of the Icahn School of Medicine at Mount Sinai presented on the role of ileocecal resection as primary treatment for recently diagnosed patients with ileocecal Crohn disease.
Dr Manasi Agrawal of the Icahn School of Medicine at Mount Sinai presented on the role of ileocecal resection as primary treatment for recently diagnosed patients with ileocecal Crohn disease.
Dr Manasi Agrawal of the Icahn...
05/07/2023
Advances in Inflammatory Bowel Disease Network
Bincy Abraham, MD
Conference Coverage
Bincy Abraham on Caring for Crohn Disease Patients With Special Circumstances
04/25/2023
Dr Abraham elaborates on dealing with issues of infection, risks of malignancy, and pregnancy when caring for patients with Crohn disease.
Dr Abraham elaborates on dealing with issues of infection, risks of malignancy, and pregnancy when caring for patients with Crohn disease.
Dr Abraham elaborates on dealing...
04/25/2023
Advances in Inflammatory Bowel Disease Network
Gil Y. Melmed, MD
Conference Coverage
Gil Melmed, MD, Reviews the Role of Interleukin Inhibitors in IBD
04/24/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Gil Y. Melmed, MD, reviewed key efficacy and safety data for approved and emerging interleukin IL-12/23 and IL-23p19 inhibitors for the management of inflammatory bowel disease.
Gil Y. Melmed, MD, reviewed key efficacy and safety data for approved and emerging interleukin IL-12/23 and IL-23p19 inhibitors for the management of inflammatory bowel disease.
Gil Y. Melmed, MD, reviewed key...
04/24/2023
Advances in Inflammatory Bowel Disease Network
Jessica Allegretti, MD
Conference Coverage
Jessica Allegretti, MD, Reviews Integrated Care Models in IBD Management
04/21/2023
Dr Jessica Allegretti addresses the holistic approach to care of patients with inflammatory bowel disease to include active monitoring, follow-up, patient education, and tight control.
Dr Jessica Allegretti addresses the holistic approach to care of patients with inflammatory bowel disease to include active monitoring, follow-up, patient education, and tight control.
Dr Jessica Allegretti addresses...
04/21/2023
Advances in Inflammatory Bowel Disease Network
Florian Rieder, MD
Conference Coverage
Florian Rieder, MD: Positioning Biologics Effectively in the Treatment of IBD
04/14/2023
Biologics can help in achieving and maintain remission among patients with Crohn disease, but is it true for patients with ulcerative colitis too? Dr Florian Rieder discussed antitumor necrosis factors and anti-integrins in the treatment of...
Biologics can help in achieving and maintain remission among patients with Crohn disease, but is it true for patients with ulcerative colitis too? Dr Florian Rieder discussed antitumor necrosis factors and anti-integrins in the treatment of...
Biologics can help in achieving...
04/14/2023
Advances in Inflammatory Bowel Disease Network
Jessica Allegretti, MD
Conference Coverage
Jessica Allegretti, MD, Reviews Top IBD Management Strategies
03/31/2023

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
A good management strategy in IBD care is one that successfully changes the disease course and improves quality of life.
A good management strategy in IBD care is one that successfully changes the disease course and improves quality of life.
A good management strategy in...
03/31/2023
Advances in Inflammatory Bowel Disease Network
Saurabh Mehandru
Podcast
Saurabh Mehandru, MD, on Durability of Response to p19 Inhibitors in IBD
03/24/2023
Dr. Mehandru reviews the results of 3 pivotal clinical trials on p19 inhibitors where the drug effect was found to be sustained for an extended period following drug withdrawal.
Dr. Mehandru reviews the results of 3 pivotal clinical trials on p19 inhibitors where the drug effect was found to be sustained for an extended period following drug withdrawal.
Dr. Mehandru reviews the results...
03/24/2023
Advances in Inflammatory Bowel Disease Network
Ed Loftus
Video
Edward Loftus, MD, on Upadacitinib for Crohn Disease
03/17/2023
Dr Loftus, from Mayo Clinic-Rochester discusses the results from a maintenance trial of upadacitinib in the treatment of Crohn disease.
Dr Loftus, from Mayo Clinic-Rochester discusses the results from a maintenance trial of upadacitinib in the treatment of Crohn disease.
Dr Loftus, from Mayo...
03/17/2023
Advances in Inflammatory Bowel Disease Network
Aline Charabaty
Conference Coverage
Aline Charabaty, MD, on Managing Mild Crohn Disease
03/12/2023
Dr Charabaty, from Johns Hopkins Sibley Memorial Hospital in Washington, DC, reviews her presentation from Advances in Inflammatory Bowel Disease 2022 on treating mild Crohn disease in adults and children.
Dr Charabaty, from Johns Hopkins Sibley Memorial Hospital in Washington, DC, reviews her presentation from Advances in Inflammatory Bowel Disease 2022 on treating mild Crohn disease in adults and children.
Dr Charabaty, from Johns Hopkins...
03/12/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Latest News

News
Vedolizumab Success Rate Appears Low in Active Perianal Crohn Disease
02/21/2020
Perianal Crohn disease (CD) is persistent, and treating patients is challenging. Authors of a new study sought to assess the effectiveness of vedolizumab in perianal CD and the predictors of success in a real‐life cohort.
Perianal Crohn disease (CD) is persistent, and treating patients is challenging. Authors of a new study sought to assess the effectiveness of vedolizumab in perianal CD and the predictors of success in a real‐life cohort.
Perianal Crohn disease (CD) is...
02/21/2020
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistance in CD Patients With Prior Biologic Use
08/26/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
08/26/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Provides Rapid Response in Crohn's Disease
08/12/2024
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction...
08/12/2024
Advances in Inflammatory Bowel Disease Network
News
Colorectal Cancer Risk Higher Among Patients WIth PSC, With or Without IBD
07/24/2024
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.
Extended screening and...
07/24/2024
Gastroenterology
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
05/24/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
05/24/2024
Advances in Inflammatory Bowel Disease Network
fecal calprotectin test
News
Fecal Calprotectin: Effective Marker In Understanding Progression of Crohn's Disease
05/09/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of...
05/09/2024
Advances in Inflammatory Bowel Disease Network
News
Study Finds Higher-Than-Expected IBD Rates in US Black Women
05/02/2024

Jolynn Tumolo

Jolynn Tumolo
The incidence of inflammatory bowel disease was highest among Black women younger than 30 years of age.
The incidence of inflammatory bowel disease was highest among Black women younger than 30 years of age.
The incidence of inflammatory...
05/02/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Subcutaneous Vedolizumab for Maintenance Therapy in Crohn’s Disease
04/22/2024
The US Food and Drug Administration approved a subcutaneous formulation of vedolizumab for moderate to severe Crohn's disease.
The US Food and Drug Administration approved a subcutaneous formulation of vedolizumab for moderate to severe Crohn's disease.
The US Food and Drug...
04/22/2024
Advances in Inflammatory Bowel Disease Network
Bharati Kochar
Conference Coverage
Bharati Kochar, MD, on Comparative Effectiveness in Positioning Therapies in Ulcerative Colitis
04/10/2024
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about...
04/10/2024
Advances in Inflammatory Bowel Disease Network
News
Post-Menopausal Women With IBD and Hormone Replacement Therapy
04/05/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Investigators sought to determine the effects of hormone replacement therapy on disease activity among post-menopausal women with IBD.
Investigators sought to determine the effects of hormone replacement therapy on disease activity among post-menopausal women with IBD.
Investigators sought to...
04/05/2024
Advances in Inflammatory Bowel Disease Network
News
Extended Mirikizumab Induction Benefits Slower Responders in UC Trials
03/20/2024

Jolynn Tumolo

Jolynn Tumolo
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week...
03/20/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Latest Podcasts

IBD logo
Podcast
IBD Drive Time: Importance of Diet in the Management of Crohn's Disease
05/25/2023

featuring James Lewis, MD, and Raymond Cross, MD

featuring James Lewis, MD, and Raymon...
In the third episode of IBD Drive Time, host Raymond Cross, MD, discusses research into how diet can alleviate symptoms—or worsen disease—among patients with Crohn's disease with Dr James Lewis, who conducted the DINE-CD study.
In the third episode of IBD Drive Time, host Raymond Cross, MD, discusses research into how diet can alleviate symptoms—or worsen disease—among patients with Crohn's disease with Dr James Lewis, who conducted the DINE-CD study.
In the third episode of IBD...
05/25/2023
Advances in Inflammatory Bowel Disease Network
Saurabh Mehandru
Podcast
Saurabh Mehandru, MD, on Durability of Response to p19 Inhibitors in IBD
03/24/2023
Dr. Mehandru reviews the results of 3 pivotal clinical trials on p19 inhibitors where the drug effect was found to be sustained for an extended period following drug withdrawal.
Dr. Mehandru reviews the results of 3 pivotal clinical trials on p19 inhibitors where the drug effect was found to be sustained for an extended period following drug withdrawal.
Dr. Mehandru reviews the results...
03/24/2023
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Sara Horst, MD, on Risankizumab for Crohn Disease
07/12/2022
In this episode of IBD Drive Time, hosts Raymond Cross, MD, and Millie Long, MD, talk to Dr Sara Horst of Vanderbilt University about the newly approved IL-23 inhibitor, risankizumab, and its benefit in treating inflammatory bowel disease.
In this episode of IBD Drive Time, hosts Raymond Cross, MD, and Millie Long, MD, talk to Dr Sara Horst of Vanderbilt University about the newly approved IL-23 inhibitor, risankizumab, and its benefit in treating inflammatory bowel disease.
In this episode of IBD Drive...
07/12/2022
Advances in Inflammatory Bowel Disease Network
Phillip Fleshner
Podcast
Phillip Fleshner, MD, on Perianal/Fistulizing Crohn's Disease
04/30/2022
In this podcast, Dr Phillip Fleshner, director of colorectal surgery at Cedars-Sinai Medical Center in Los Angeles, discusses the complexities of medical and surgical treatment of perianal and fistulizing Crohn disease, which he spoke about...
In this podcast, Dr Phillip Fleshner, director of colorectal surgery at Cedars-Sinai Medical Center in Los Angeles, discusses the complexities of medical and surgical treatment of perianal and fistulizing Crohn disease, which he spoke about...
In this podcast, Dr Phillip...
04/30/2022
Advances in Inflammatory Bowel Disease Network
David Schwartz, MD
Podcasts
David Schwartz, MD, on the ENTERPRISE Study of Vedolizumab for Perianal Crohn Disease
12/30/2021
In this podcast, Dr Schwartz, from Vanderbilt University, discusses the ENTERPRISE multinational program that examined the efficacy and safety of vedolizumab for perianal Crohn’s disease.
In this podcast, Dr Schwartz, from Vanderbilt University, discusses the ENTERPRISE multinational program that examined the efficacy and safety of vedolizumab for perianal Crohn’s disease.
In this podcast, Dr Schwartz,...
12/30/2021
Advances in Inflammatory Bowel Disease Network
Adam Cheifetz
Podcast
Adam Cheifetz, MD, and Konstantinos Papamichail, MD, on Therapeutic Drug Monitoring in Fistulizing Crohn Disease
09/03/2021
In this podcast, Adam Cheifetz, MD, director of the Center for Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center and associate professor at Harvard Medical School, and Konstantinos Papamichail, M.D., Ph.D., instructor in...
In this podcast, Adam Cheifetz, MD, director of the Center for Inflammatory Bowel Disease at Beth Israel Deaconess Medical Center and associate professor at Harvard Medical School, and Konstantinos Papamichail, M.D., Ph.D., instructor in...
In this podcast, Adam Cheifetz,...
09/03/2021
Advances in Inflammatory Bowel Disease Network
Sara Horst, MD, and David Schwartz, MD, on Current and Upcoming Treatments for Perianal Crohn Disease
Podcasts
Sara Horst, MD, and David Schwartz, MD, on Current and Upcoming Treatments for Perianal Crohn Disease
05/07/2021
In this podcast, Drs Sara Horst and David Schwartz of Vanderbilt University wrap up their podcast series on perinanal Crohn disease with a discussion of existing and upcoming therapies and procedures.
In this podcast, Drs Sara Horst and David Schwartz of Vanderbilt University wrap up their podcast series on perinanal Crohn disease with a discussion of existing and upcoming therapies and procedures.
In this podcast, Drs Sara Horst...
05/07/2021
Advances in Inflammatory Bowel Disease Network
Sara Horst, MD, and David Schwartz, MD, on Refractory Perianal Crohn's Disease
Podcasts
Sara Horst, MD, and David Schwartz, MD, on Refractory Perianal Crohn's Disease
04/26/2021
Drs Sara Horst and David Schwartz from Vanderbilt University continue their podcast series on Crohn disease in this discussion about the challenges of treating the patient with refractory Crohn disease and their approach to controlling the...
Drs Sara Horst and David Schwartz from Vanderbilt University continue their podcast series on Crohn disease in this discussion about the challenges of treating the patient with refractory Crohn disease and their approach to controlling the...
Drs Sara Horst and David...
04/26/2021
Advances in Inflammatory Bowel Disease Network
Sara Horst, MD and David Schwartz, MD, on Surgery and Therapies for Perianal Crohn Disease
Podcasts
Sara Horst, MD and David Schwartz, MD, on Surgery and Therapies for Perianal Crohn Disease
04/08/2021
In this second podcast of a series on the care of patients with perianal Crohn disease, Dr Horst and Dr Schwartz, both from Vanderbilt University, discuss when to involve a surgeon and the preferred medical therapies used to treat this...
In this second podcast of a series on the care of patients with perianal Crohn disease, Dr Horst and Dr Schwartz, both from Vanderbilt University, discuss when to involve a surgeon and the preferred medical therapies used to treat this...
In this second podcast of a...
04/08/2021
Advances in Inflammatory Bowel Disease Network
Sara Horst, MD, and David Schwartz, MD, on Managing Patient Expectations in Treating Crohn Disease
Podcasts
Sara Horst, MD, and David Schwartz, MD, on Managing Patient Expectations in Treating Crohn Disease
03/26/2021
In part 1 of a 5-part series on the challenges of treating perianal Crohn disease, Sara Horst, MD, and David Schwartz, MD, from Vanderbilt University Medical Center, discuss how to manage patient expectations concerning treatment and outcomes.
In part 1 of a 5-part series on the challenges of treating perianal Crohn disease, Sara Horst, MD, and David Schwartz, MD, from Vanderbilt University Medical Center, discuss how to manage patient expectations concerning treatment and outcomes.
In part 1 of a 5-part series on...
03/26/2021
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
06/24/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
06/24/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of ECCO With Dr Frank Farraye
06/12/2024
Dr Frank Farraye, director of the IBD Center at Mayo Jacksonville, joins IBD Drive Time hosts Millie Long, MD, and Raymond Cross, MD, to review the best of presentations on the natural history of IBD at the European Crohn's & Colitis...
Dr Frank Farraye, director of the IBD Center at Mayo Jacksonville, joins IBD Drive Time hosts Millie Long, MD, and Raymond Cross, MD, to review the best of presentations on the natural history of IBD at the European Crohn's & Colitis...
Dr Frank Farraye, director of...
06/12/2024
Advances in Inflammatory Bowel Disease Network
Rishika Chugh
Podcast
Rishika Chugh, MD: Safety of Vedolizumab and Ustekinumab in Pregnancy
05/28/2024
Dr Chugh reviews the results of a recent study of the safety of ustekinumab and vedolizumab among pregnant patients with inflammatory bowel disease.
Dr Chugh reviews the results of a recent study of the safety of ustekinumab and vedolizumab among pregnant patients with inflammatory bowel disease.
Dr Chugh reviews the results of...
05/28/2024
Advances in Inflammatory Bowel Disease Network
Noa Cleveland
Podcast
Noa Krugliak Cleveland, MD, on Intestinal Ultrasound in Clinical Practice
05/22/2024
Dr Krugliak Cleveland reviews the results of research and real-world experience in using intestinal ultrasound in clinical practice when diagnosing and monitoring inflammatory bowel disease.
Dr Krugliak Cleveland reviews the results of research and real-world experience in using intestinal ultrasound in clinical practice when diagnosing and monitoring inflammatory bowel disease.
Dr Krugliak Cleveland reviews...
05/22/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Gary Lichtenstein, MD, on the Best of ECCO
05/06/2024
IBD Drive Time continues its coverage of the European Crohn's & Colitis Organization meeting as Dr Gary Lichtenstein shares his choices on the best abstracts with host Dr Raymond Cross.
IBD Drive Time continues its coverage of the European Crohn's & Colitis Organization meeting as Dr Gary Lichtenstein shares his choices on the best abstracts with host Dr Raymond Cross.
IBD Drive Time continues its...
05/06/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
Siddharth Singh: AGA Guidelines on Using Biomarkers in Ulcerative Colitis
04/25/2024
In this episode of IBD Drive Time, cohost Raymond Cross, MD, talks with Siddharth Singh, MD, about the latest guidelines from the American Gastroenterological Association on caring for patients with ulcerative colitis.
In this episode of IBD Drive Time, cohost Raymond Cross, MD, talks with Siddharth Singh, MD, about the latest guidelines from the American Gastroenterological Association on caring for patients with ulcerative colitis.
In this episode of IBD Drive...
04/25/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement